Assessment of the Long-term Diagnostic Performance of a New Serological Screening Scheme in Large-scale Nasopharyngeal Carcinoma Screening.

about

Assessment of the Long-term Diagnostic Performance of a New Serological Screening Scheme in Large-scale Nasopharyngeal Carcinoma Screening.

Item

http://www.wikidata.org/entity/Q55280881

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Assessment of the Long-term Di ...... haryngeal Carcinoma Screening.

@en

Assessment of the Long-term Di ...... haryngeal Carcinoma Screening.

@nl

type

Item

label

Assessment of the Long-term Di ...... haryngeal Carcinoma Screening.

@en

Assessment of the Long-term Di ...... haryngeal Carcinoma Screening.

@nl

prefLabel

Assessment of the Long-term Di ...... haryngeal Carcinoma Screening.

@en

Assessment of the Long-term Di ...... haryngeal Carcinoma Screening.

@nl

P1476

Assessment of the Long-term Di ...... pharyngeal Carcinoma Screening

@en

P2093

Biaohua Wu

http://www.w3.org/2001/XMLSchema#string

Sumei Cao

http://www.w3.org/2001/XMLSchema#string

Weimin Cheng

http://www.w3.org/2001/XMLSchema#string

Xia Yu

http://www.w3.org/2001/XMLSchema#string

Yun Du

http://www.w3.org/2001/XMLSchema#string

P2860

Phases of biomarker development for early detection of cancer.

Trends in the survival of patients with nasopharyngeal carcinoma between 1976 and 2005 in Sihui, China: a population-based study.

Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.

Trends in nasopharyngeal carcinoma mortality in China, 1973-2005.

Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China.

[The following-up study of high-risk and moderate-risk groups defined by EB virus serology test at the nasopharyngeal carcinoma screening programme].

Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program.

Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China.

No incidence trends and no change in pathological proportions of nasopharyngeal carcinoma in Zhongshan in 1970-2007.

An efficacy analysis for nasopharyngeal carcinoma screening of different screening intervals.

P304

2093-2097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.23755

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mingfang Ji

P577

2018-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29937927

http://www.w3.org/2001/XMLSchema#string

P932

6010686

http://www.w3.org/2001/XMLSchema#string